Growth stimulation of human pulmonary adenocarcinoma cells and small airway epithelial cells by β-carotene via activation of cAMP, PKA, CREB and ERK1/2

International Journal of Cancer

Volumn 118, Issue 6, 2006, Pages 1370-1380

  Al Wadei, Hussein A N ^a   Takahashi, Takashi ^b   Schuller, Hildegard M ^a  

^a UNIVERSITY OF TENNESSEE   (United States)

^b NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

carotene; Growth stimulation; Human lung adenocarcinoma; Signal transduction

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 9 (TETRAHYDRO 2 FURYL)ADENINE; BETA CAROTENE; CYCLIC AMP; CYCLIC AMP DEPENDENT PROTEIN KINASE; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; DIMETHYL SULFOXIDE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; RETINOID; RETINOL;

AGAR GEL ELECTROPHORESIS; ARTICLE; CANCER GROWTH; CANCER PREVENTION; CARDIOVASCULAR DISEASE; CELL PROLIFERATION; CHEMOPROPHYLAXIS; CLARA CELL; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFECT; ENZYME PHOSPHORYLATION; GROWTH STIMULATION; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; LUNG ADENOCARCINOMA; MORTALITY; PRIORITY JOURNAL; RESPIRATORY EPITHELIUM; SIGNAL TRANSDUCTION; STATISTICAL ANALYSIS; VITAMIN SUPPLEMENTATION; WESTERN BLOTTING;

ADENOCARCINOMA; ANALYSIS OF VARIANCE; BETA CAROTENE; BLOTTING, WESTERN; CELL LINE; CELL LINE, TUMOR; CELL PROLIFERATION; CYCLIC AMP; CYCLIC AMP RESPONSE ELEMENT-BINDING PROTEIN; CYCLIC AMP-DEPENDENT PROTEIN KINASES; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME ACTIVATION; EPITHELIAL CELLS; HUMANS; LUNG; LUNG NEOPLASMS; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; PHOSPHORYLATION; PROTEIN-SERINE-THREONINE KINASES; TIME FACTORS; VITAMINS;

EID: 33644500427     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.21537     Document Type: Article

References (56)

1. Kelly A, Blair N, Pechacek TF. Women and smoking: issues and opportunities. J Womens Health Gend Based Med 2001;10:515-8.
2. Levi F, Franceschi S, La Vecchia C, Randimbison L, Te VC. Lung carcinoma trends by histologic type in Vaud and Neuchatel, Switzerland, 1974-1994. Cancer 1997;79:906-14.
3. Weir HK, Thun MJ, Hankey BF, Ries LA, Howe HL, Wingo PA, Jemal A, Ward E, Anderson RN, Edwards BK. Annual report to the nation on the status of cancer, 1975-2000, featuring the uses of surveillance data for cancer prevention and control. J Natl Cancer Inst 2003;95:1276-99.
4. Hoffmann D, Rivenson A, Hecht SS. The biological significance of tobacco-specific N-nitrosamines: smoking and adenocarcinoma of the lung. Crit Rev Toxicol 1996;26:199-211.
5. Wynder EL, Muscat JE. The changing epidemiology of smoking and lung cancer histology. Environ Health Perspect 1995;103(Suppl. 8):143-8.
6. Burns DM. Tobacco-related diseases. Semin Oncol Nurs 2003;19:244-9.
7. Hoffmann D, Rivenson A, Chung FL, Hecht SS, Nicotine-derived N-nitrosamines (TSNA) and their relevance in tobacco carcinogenesis. Crit Rev Toxicol 1991;21:305-11.
8. Alavanja MC, Brown CC, Swanson C, Brownson RC. Saturated fat intake and lung cancer risk among nonsmoking women in Missouri. J Natl Cancer Inst 1993;85:1906-16.
9. Alavanja MC, Field RW, Sinha R, Brus CP, Shavers VL, Fisher EL, Curtain J, Lynch CF. Lung cancer risk and red meat consumption among Iowa women. Lung Cancer 2001;34:37-46.
10. Veierod MB, Laake P, Thelle DS. Dietary fat intake and risk of lung cancer: a prospective study of 51,452 Norwegian men and women. Eur J Cancer Prev 1997;6:540-9.
11. Broers JL, Jensen SM, Travis WD, Pass H, Whitsett JA, Singh G, Katyal SL, Gazdar AF, Minna JD, Linnoila RI. Expression of surfactant associated protein-A and Clara cell 10 kilodalton mRNA in neoplastic and non-neoplastic human lung tissue as detected by in situ hybridization. Lab Invest 1992;66:337-46.
12. Albertine KH, Steiner RM, Radack DM, Golding DM, Peterson D, Cohn HE, Farber JL. Analysis of cell type and radiographic presentation as predictors of the clinical course of patients with bronchioalveolar cell carcinoma. Chest 1998;113:997-1006.
13. Linnoila RI, Szabo E, DeMayo F, Witschi H, Sabourin C, Malkinson A. The role of CC10 in pulmonary carcinogenesis: from a marker to tumor suppression. Ann N Y Acad Sci 2000;923:249-67.
14. Schuller HM, Tithof PK, Williams M, Plummer H, III. The tobacco-specific carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone is a beta-adrenergic agonist and stimulates DNA synthesis in lung adenocarcinoma via beta-adrenergic receptor-mediated release of arachidonic acid. Cancer Res 1999;59:4510-5.
15. Adissu HA, Schuller HM. Antagonistic growth regulation of cell lines derived from human lung adenocarcinomas of Clara cell and alveolar type II cell lineage: implications for chemoprevention. Int J Oncol 2004;24:1467-72.
16. Schuller HM, Porter B, Riechert A. Beta-adrenergic modulation of NNK-induced lung carcinogenesis in hamsters. J Cancer Res Clin Oncol 2000;126:624-30.
17. Schuller HM, Porter B, Riechert A, Walker K, Schmoyer R. Neuroendocrine lung carcinogenesis in hamsters is inhibited by green tea or theophylline while the development of adenocarcinomas is promoted: implications for chemoprevention in smokers. Lung Cancer 2004;45:11-8.
18. The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers. The Alpha-Tocopherol, Beta Carotene Cancer Prevention Study Group. N Engl J Med 1994;330:1029-35.
19. Brodkin CA, McCullough J, Stover B, Balmes J, Hammar S, Omenn GS, Checkoway H, Bamhart S, Lobe of origin and histologic type of lung cancer associated with asbestos exposure in the Carotene and Retinol Efficacy Trial (CARET). Am J Ind Med 1997;32:582-91.
20. Omenn GS, Goodman GE, Thornquist MD, Balmes J, Cullen MR, Glass A, Keogh JP, Meyskens FL, Valanis B, Williams JH, Bamhart S, Hammar S. Effects of a combination of beta carotene and vitamin A on lung cancer and cardiovascular disease. N Engl J Med 1996;334:1150-5.
21. Peto R, Doll R, Buckley JD, Sporn MB. Can dietary beta-carotene materially reduce human cancer rates? Nature 1981;290:201-8.
22. Newton DL, Henderson WR, Sporn MB. Structure-activity relationships of retinoids in hamster tracheal organ culture. Cancer Res 1980;40:3413-25.
23. Sporn MB, Dunlop NM, Newton DL, Smith JM. Prevention of chemical carcinogenesis by vitamin A and its synthetic analogs (retinoids). Fed Proc 1976;35:1332-8.
24. Sporn MB, Newton DL. Chemoprevention of cancer with retinoids. Fed Proc 1979;38:2528-34.
25. Harris CC, Sporn MB, Kaufman DG, Smith JM, Jackson FE, Saffiotti U. Histogenesis of squamous metaplasia in the hamster tracheal epithelium caused by vitamin A deficiency or benzo[a]pyrene-ferric oxide. J Natl Cancer Inst 1972;48:743-61.
26. Clamon GH, Sporn MB, Smith JM, Saffiotti U. Alpha- and beta-retinyl acetate reverse metaplasias of vitamin A deficiency in hamster trachea in organ culture. Nature 1974;250:64-6.
27. Kaplan JR, Manuck SB. Antiatherogenic effects of beta-adrenergic blocking agents: theoretical, experimental, and epidemiologic considerations. Am Heart J 1994;128(Part 2):1316-28.
28. Prasad KN, Kentroti S, Edwards-Prasad J, Vernadakis A, Imam M, Carvalho E, Kumar S. Modification of the expression of adenosine 3′,5′-cyclic monophosphate-induced differentiated functions in neuroblastoma cells by beta-carotene and D-alpha-tocopheryl succinate. J Am Coll Nutr 1994;13:298-303.
29. Masiida A, Kondo M, Saito T, Yatabe Y, Kobayashi T, Okamoto M, Suyama M, Takahashi T. Establishment of human peripheral lung epithelial cell lines (HPL1) retaining differentiated characteristics and responsiveness to epidermal growth factor, hepatocyte growth factor, and transforming growth factor beta1. Cancer Res 1997;57:4898-904.
30. Schuller HM, Cekanova M. NNK-induced hamster lung adenocarcinomas over-express beta2-adrenergic and EGFR signaling pathways. Lung Cancer 2005;49:35-45.
31. Wallukat G. The beta-adrenergic receptors. Herz 2002;27:683-90.
32. Rosenberg D, Groussin L, Jullian E, Perlemoine K, Bertagna X, Bertherat J. Role of the PKA-regulated transcription factor CREB in development and tumorigenesis of endocrine tissues. Ann N Y Acad Sci 2002;968:65-74.
33. Muller FU, Boknik P, Knapp J, Linck B, Luss H, Neumann J, Schmitz W. Activation and inactivation of cAMP-response element-mediated gene transcription in cardiac myocytes. Cardiovasc Res 2001;52:95-102.
34. Pursiheimo JP, Kieksi A, Jalkanen M, Salmivirta M. Protein kinase A balances the growth factor-induced Ras/ERK signaling. FEBS Lett 2002;521:157-64.
35. Nishihara H, Hwang M, Kizaka-Kondoh S, Eckmann L, Insel PA. Cyclic AMP promotes cAMP-responsive element-binding protein-dependent induction of cellular inhibitor of apoptosis protein-2 and suppresses apoptosis of colon cancer cells through ERK1/2 and p38 MAPK. J Biol Chem 2004;279:26176-83.
36. Lee MK, Nikodem VM. Differential role of ERK in cAMP-induced Nurr1 expression in N2A and C6 cells. Neuroreport 2004;15:99-102.
37. Moon RC, Rao KV, Detrisac CJ, Kelloff GJ. Hamster lung cancer model of carcinogenesis and chemoprevention. Adv Exp Med Biol 1992;320:55-61.
38. Niles RM, Loewy BP, Brown K. The effect of retinoic acid on growth and proto-oncogene expression in hamster tracheal epithelial cells. Am J Respir Cell Mol Biol 1990;2:365-71.
39. Sporn MB. Vitamin A and its analogs (retinoids) in cancer prevention. Curr Concepts Nutr 1977;6:119-30.
40. Markus R, Coulston AM. Fat-soluble vitamins. In: Gilman AG, Rail TW, Nies AS, Taylor P, eds. The pharmacological basis of therapeutics, 8th ed. New York: Pergamon Press, 1990:1553-71.
41. Mey J, McCaffery P. Retinoic acid signaling in the nervous system of adult vertebrates. Neuroscientist 2004;10:409-21.
42. Karp DD, Tsao AS, Kim ES. Nonsmall-cell lung cancer: chemoprevention studies. Semin Thorac Cardiovasc Surg 2003;15:405-20.
43. Khuri FR, Cohen V. Molecularly targeted approaches to the chemoprevention of lung cancer. Clin Cancer Res 2004;10(Part 2):4249s-53s.
44. Rhee JC, Khuri FR, Shin DM. Advances in chemoprevention of head and neck cancer. Oncologist 2004;9:302-11.
45. Parrella E, Gianni M, Cecconi V, Nigro E, Barzago MM, Rambaldi A, Rochette-Egly C, Terao M, Garattini E. Phosphodiesterase IV inhibition by piclamilast potentiates the cytodifferentiating action of retinoids in myeloid leukemia cells. Cross-talk between the cAMP and the retinoic acid signaling pathways. J Biol Chem 2004;279:42026-40.
46. Garattini E, Parrella E, Diomede L, Gianni M, Kalac Y, Merlini L, Simoni D, Zanier R, Ferrara FF, Chiarucci I, Carminati P, Terao M, et al. ST1926, a novel and orally active retinoid-related molecule inducing apoptosis in myeloid leukemia cells: modulation of intracellular calcium homeostasis. Blood 2004;103:194-207.
47. Lippman SM, Lee JJ, Karp DD, Vokes EE, Benner SE, Goodman GE, Khuri FR, Marks R, Winn RJ, Fry W, Graziano SL, Gandara DR, et al. Randomized phase III intergroup trial of isotretinoin to prevent second primary tumors in stage I non-small-cell lung cancer. J Natl Cancer Inst 2001;93:605-18.
48. Schuller HM. Mechanisms of smoking-related lung and pancreatic adenocarcinoma development. Nat Rev Cancer 2002;2:455-63.
49. Rodriguez AM, Sastre S, Ribot J, Paliu A. Beta-carotene uptake and metabolism in human lung bronchial epithelial cultured cells depending on delivery system. Biochim Biophys Acta 2005;1740:132-38.
50. Heasley LE. Autocrine and paracrine signaling through neuropeptide receptors in human cancer. Oncogene 2001;20:1563-9.
51. Lee JT, Jr., McCubrey JA. The Raf/MEK/ERK signal transduction cascade as a target for chemotherapeutic intervention in leukemia. Leukemia 2002;16:486-507.
52. Price DT, Rocca GD, Guo C, Ballo MS, Schwinn DA, Luttrell LM. Activation of extracellular signal-regulated kinase in human prostate cancer. J Urol 1999;162:1537-42.
53. Vicent S, Lopez-Picazo JM, Toledo G, Lozano MD, Torre W, Garcia-Corchon C, Quero C, Soria JC, Martin-Algarra S, Manzano RG, Montuenga LM. ERK1/2 is activated in non-small-cell lung cancer and associated with advanced tumours. Br J Cancer 2004;90:1047-52.
54. Mishima K, Inoue K, Hayashi Y. Overexpression of extracellular-signal regulated kinases on oral squamous cell carcinoma. Oral Oncol 2002;38:468-74.
55. Blackball FH, Pintilie M, Michael M, Leighl N, Feld R, Tsao MS, Shepherd FA. Expression and prognostic significance of kit, protein kinase B, and mitogen-activated protein kinase in patients with small cell lung cancer. Clin Cancer Res 2003;9:2241-7.
56. Shafer SH, Phelps SH, Williams CL. Reduced DNA synthesis and cell viability in small cell lung carcinoma by treatment with cyclic AMP phosphodiesterase inhibitors. Biochem Pharmacol 1998;56:1229-36.